Skip to main content
HHS Author Manuscripts logoLink to HHS Author Manuscripts
. Author manuscript; available in PMC: 2023 Sep 6.
Published in final edited form as: Arthritis Care Res (Hoboken). 2021 Jan;73(1):65–77. doi: 10.1002/acr.24381

Depressive Symptoms and the Arthritis-Employment Interface: A Population-Level Study

Arif Jetha 1, Kristina A Theis 2, Michael A Boring 3, Louise B Murphy 2, Dana Guglielmo 4
PMCID: PMC10481427  NIHMSID: NIHMS1924012  PMID: 32702187

Abstract

Objective.

To examine the relationship between depressive symptoms, arthritis, and employment, and to determine whether this relationship differs across young, middle-age, and older working-age adults with arthritis.

Methods.

Data from the US National Health Interview Survey from 2013–2017 were analyzed. Analyses were restricted to adults with doctor-diagnosed arthritis of working age (ages 18–64 years) with complete data on depressive symptoms (n = 11,380). Covariates were sociodemographic information, health, and health system utilization variables. Employment prevalence was compared by self-reported depressive symptoms. We estimated percentages, as well as univariable and multivariable logistic regression models, to examine the relationship between depression and employment among young adults (ages 18–34 years), middle-age adults (ages 35–54 years), and older adults (ages 55–64 years).

Results.

Among all working-age US adults with arthritis, the prevalence of depressive symptoms was 13%. Those reporting depressive symptoms had a higher prevalence of fair/worse health (60%) and arthritis-attributable activity limitations (70%) compared to those not reporting depression (23% and 39%, respectively). Respondents with depressive symptoms reported significantly lower employment prevalence (30%) when compared to those not reporting depressive symptoms (66%) and lower multivariable-adjusted association with employment (prevalence ratio 0.88 [95% confidence interval (95% CI) 0.83–0.93]). Middle-age adults reporting depression were significantly less likely to be employed compared to their counterparts without depression (prevalence ratio 0.83 [95% CI 0.77–0.90]); similar but borderline statistically significant relationships were observed for both young adults (prevalence ratio 0.86 [95% CI 0.74–0.99]) and older adults (prevalence ratio 0.94 [95% CI 0.86–1.03]).

Conclusion.

For adults with arthritis, depressive symptoms are associated with not participating in employment. Strategies to reduce arthritis-related work disability may be more effective if they simultaneously address mental health.

INTRODUCTION

Arthritis is one the most common causes of work disability in the US (1). Research on working-age adults (ages 18–64 years) indicates that arthritis is consistently associated with challenges in finding and sustaining employment and remaining productive at work (24). Emerging evidence also indicates that working-age adults with arthritis are more likely to live with depression when compared to adults without arthritis (5,6). Few studies have examined the role of depression in those living with arthritis who are unemployed, and whether differences exist across young adults (ages 18–34 years), middle-age adults (ages 35–54 years), and older working-age adults (ages 55–64 years).

In the US, 54 million adults are estimated to be living with arthritis, of which approximately three-fourths are working age (7). Among young, middle-age, and older working-age adults, arthritis is associated with not participating in employment (8,9). Those who are able to find paid work report workplace activity limitations, absenteeism, and presenteeism (24,10). Studies indicate that greater arthritis symptom severity (e.g., pain, fatigue, disease activity, and inflammation) and lower access to support within the workplace (e.g., job accommodations) are associated with challenges in employment and with difficulties at work (1113). In addition, the employment experiences of people with arthritis can differ according to age and career phase (14).

It is important to acknowledge that employment is a critical social determinant of health for people with arthritis across the life course. Those experiencing challenges with work participation are more likely to report worse health status and a lower quality of life (15,16). The economic implications are also significant. Estimates from 2013 indicate that earnings losses attributed to arthritis totaled approximately $164 billion (17). Therefore, promoting the employment engagement of working-age adults with arthritis has significant personal and societal implications.

A number of studies indicate that adults with different forms of arthritis (5), including inflammatory arthritis (6) and osteoarthritis (18), are more likely to report depression compared to those without arthritis. Using the nationally representative National Health Interview Survey (NHIS), a recent study found that adults with arthritis are significantly more likely to report depressive symptoms (22.5%) compared to those without arthritis (10.7%) (5). Other research indicates that adults living with arthritis and depression are more likely to report greater symptom severity (e.g., pain, fatigue, disease activity, and inflammation) (1921), functional limitations (18), and role participation restrictions when compared with those without depression (19,22).

Research among adults without arthritis highlights an interrelationship between depression and unemployment, underemployment, and productivity loss (2326). Moreover, the co-occurrence of depression and a physical impairment can exacerbate employment difficulties (27,28). A population-based study of 22,118 working-age Canadians indicated that having a physical and mental health condition was associated with 2-times greater odds of reporting work disability when compared to either condition alone (27). In the nationally representative US National Comorbidity Survey, the co-occurrence of physical (i.e., arthritis, hypertension, asthma, or ulcers) and mental health disorders was significantly associated with role functioning impairment when compared to either physical or mental disorders alone (28). Indeed, among working-age adults with arthritis, depression can significantly add to the challenges faced with workforce participation.

It is important to acknowledge that the relationship between depression and employment of people with arthritis may vary when examined across young, middle-age, and older working-age adults. Population-level studies suggest that young people with (5) and without arthritis (29) are more likely to report a greater prevalence of depressive symptoms when compared to middle- and/or older-age adults. At the same time, research among those not living with arthritis indicates that depressive symptoms may be more likely to disrupt employment in older-age groups (23). No studies, to our knowledge, have compared the relationship between employment and the co-occurrence of depression and arthritis at different life phases.

We used data from the NHIS to examine the relationship between self-reported depressive symptoms and employment in working-age adults with doctor-diagnosed arthritis. We also examined whether the association between arthritis, depression, and employment differed across young, middle-age, and older working-age adults. We hypothesized that, among the US population with an arthritis diagnosis, self-reported depressive symptoms would be associated with a lower prevalence of employment participation when compared to those without self-reported depression. We also hypothesized that, among those with an arthritis diagnosis, older adults with self-reported depression would have a lower prevalence of employment participation when compared to young and middle-age adults.

MATERIALS AND METHODS

Sample.

Data from 2013–2017 NHIS were combined and analyzed. The NHIS is an ongoing cross-sectional survey of the civilian noninstitutionalized population of the US conducted by the National Center for Health Statistics (NCHS) (30). The complex multistaged survey oversamples underrepresented sociodemographic subgroups (30). Data are collected in-person by trained interviewers; participation is voluntary. We analyzed data from the files for sample adult, functioning and disability supplement, and imputed income. The functioning and disability supplement, which contained the questions used to ascertain depressive symptoms, was randomly administered to one-half of sample adults in each year (30). Overall sample adult response rates ranged from 53.0% (2017) to 61.2% (2013). Of note, we restricted the analysis to those of traditional working age (ages 18 to 64 years). Our analysis was also restricted to participants with doctor-diagnosed arthritis, identified by “yes” to the question: “Have you ever been told by a doctor or other health professional that you have some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia?” (31).

Outcome measure.

The main outcome measure was employment status. Using a standard reference period of last week, respondents were asked about their employment status using the questions “What were you doing last week?” and “What is the main reason you did not work last week?” By combining responses, we classified respondents as employed, unemployed (not working but looking for work), unable to work/disabled, or other (i.e., retired, homemakers, or students, but not otherwise working). For dichotomous analyses, all categories except employed were classified as not working.

Primary independent variable.

Self-reported depressive symptoms were assessed using 2 questions generated by the NCHS using a definition developed by Guglielmo et al (5) in consultation with mental health experts and using Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition diagnostic criteria. First, participants were asked about the frequency of depressive symptoms using the question “How often do you feel depressed?” Response options were daily, weekly, monthly, a few times a year, never, or refused/don’t know. Second, participants were asked about the intensity of depressive symptoms using the question “Thinking about the last time you felt depressed, how depressed did you feel?” Response options were “a lot,” “in between a little and a lot,” “a little,” and “or refused/don’t know.” Participants who were categorized as reporting depressive symptoms selected “daily” or “weekly” for symptom frequency and indicated “a lot” or “in between a little and a lot” for depressive symptom intensity (5). Participants were also grouped into 3 categories of working-age adults based on age: young (ages 18–34 years), middle-age (ages 35–54 years), and older (ages 55–64 years) (32).

Covariates.

Sociodemographic, health, and health service use variables were examined as covariates and selected based on their relationship with employment participation of people with arthritis or depression in previous research (1,5).

Sociodemographic.

Aligning with past studies, we included information on sex, race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanic, and non-Hispanic other), and education (high school or less, high school graduate or equivalent, some college/associate degree, college graduate or above). Using imputed income files provided by NHIS, we also calculated the income-to-poverty ratio (IPR) based on total family income and family size to capture resources and demands (33). Using the IPR, participants were classified as poor/near poor (IPR <125%), low income (IPR 125–199%), middle income (IPR 200–400%), and high income (IPR >400%). Additionally, social participation restriction was identified using 2 questions that asked respondents to rate their difficulty to “go out to things like shopping, movies, or sporting events” and “participate in social activities such as visiting friends, attending clubs and meetings, going to parties?” Those who reported “very difficult” or “can’t do at all” to 1 or both questions were categorized as having social participation restriction.

Health.

We included self-reported health (categorized as excellent/very good, good, fair/poor), the number of comorbid conditions from a list of 9 (hypertension, heart diseases, stroke, diabetes mellitus, current asthma, cancer [excluding nonmelanoma skin cancer], weak or failing kidneys, hepatitis, and chronic obstructive pulmonary disease) (34) and body mass index (calculated as kg/m2 from self-reported weight and height: underweight/healthy weight [<25.0], overweight [25.0–29.9], and obese [≥30]). Similar to depressive symptoms, self-reported anxiety symptoms were assessed using 2 questions on the frequency and severity of anxiety in the past week. Participants who reported “daily or weekly” anxiety symptom frequency and indicated “a lot” or “in between a little and a lot” of anxiety were categorized as having anxiety symptoms (5).

The number of functional limitations was measured based on 9 tasks where “very difficult” or “can’t do” was reported (push/pull large objects, walk one-fourth mile, stand for 2 hours, sit for 2 hours, stoop/bend/kneel, reach over one’s head, grasp small objects, climb stairs, lift or carry 10 pounds). Those with an arthritis-attributable activity limitation were identified by “yes” to the question “Are you now limited in any way in any of your usual activities because of arthritis or joint symptoms?” Aerobic physical activity was assessed by self-reported duration of moderate- or vigorous-intensity leisure time aerobic physical activity/week. Reported vigorous-intensity physical activity minutes were counted double and added to moderate-intensity physical activity minutes. Respondents were classified as being physically active (≥150 minutes), insufficiently active (1–149 minutes), or inactive (0 minutes) (35). The presence or absence of health insurance (30), the usual place for care, and the number of ambulatory visits in the past year were assessed.

Statistical analysis.

First, we estimated the distribution of study population characteristics among those with and without self-reported depressive symptoms. Estimates were compared with nonoverlapping 95% confidence intervals (95% CIs) indicating a significant difference (36). Next, we generated prevalence estimates with 95% CIs of employment by sociodemographic, health, and health service use variables among those with and without depressive symptoms. Absolute differences between prevalence estimates of employment were calculated by comparing prevalence among participants with and without depressive symptoms. Estimates were compared with nonoverlapping 95% CIs, as well as with the computation of absolute differences in estimates and t-tests to examine significant differences (α < 0.05).

Unadjusted and multivariable-adjusted prevalence ratios from logistic regression models were used to estimate the association between depressive symptoms and employment status. For multivariable modeling, a backwards elimination strategy was used to select covariates that were significantly associated with employment in the unadjusted model and did not exhibit multicollinearity with other covariates. Because the relationship between depression and employment status can vary by age (32), we generated a multivariable model that contained all of the variables identified in the backwards elimination strategy described above, depressive symptoms, and age group. We also report estimates from the multivariable model containing the interaction term because the prevalence ratios for the model containing the interaction term were within 2% of the prevalence ratios for the multivariable model without the interaction term.

To generate nationally representative population estimates, sampling weights created by the NCHS specifically for the functioning and disability supplement (which differ from the standard sample adult weights) were adjusted for combining 5 years of data and used in all analyses. All SE estimates were adjusted for the complex survey design of the NHIS. Estimates with a relative SE of 20.0–29.9% were considered unstable and were flagged and should be interpreted with caution; estimates based on an unweighted sample size of <30 are not reported. SAS software, version 9.4 (37) and SUDAAN 11.0 (38) were used to conduct the analyses.

RESULTS

A description and comparison of the overall study population and of those with and without depressive symptoms are shown in Table 1. More than one-half of all working-age participants with arthritis were women (59%) and were of non-Hispanic White race/ethnicity (74%). Less than one-half of participants were of middle (46%) or older working-age (44%), and less than one-half reported an associate degree/some college (34%) or being a college graduate (27%) or had an IPR >400% (40%). The overall prevalence of employment was 61%.

Table 1.

Weighted distribution of sample characteristics of working-age adults (ages 18–64 years) in the US with doctor-diagnosed arthritis using the 2013–2017 National Health Interview Survey (NHIS) data, comparing those with and without self-reported depressive symptoms*

Total sample
Depressive symptoms
No depressive symptoms
Sample size Population, 1,000s % 95% CI Sample size No. weighted, 1,000s % 95% CI Sample size No. weighted, 1,000s % 95% CI
Total 11,380 32,839 1,645 4,123 13.2 12.4–14.0 9,191 27,164 86.8 86.0–87.6

Sociodemographic factors
 Sex
  Men 4,401 13,525 41.2 39.9–42.5 515 1,400 34.0 30.9–37.1 3,694 11,588 42.7 41.3–44.1
  Women 6,979 19,314 58.8 57.5–60.1 1,130 2,723 66.0 62.9–69.1 5,497 15,576 57.3 55.9–58.7
 Age, years
  Young adult (18–34) 1,027 3,319 10.1 9.4–10.9 143 443 10.7 8.7–13.1 842 2,707 10.0 9.2–10.8
  Middle-age adult (35–54) 4,928 14,937 45.5 44.3–46.7 796 2,090 50.7 47.4–53.9 3,899 12,238 45.1 43.7–46.4
  Older adult (55–64) 5,425 14,583 44.4 43.2–45.7 706 1,590 38.6 35.4–41.8 4,450 12,220 45.0 43.6–46.4
 Race/ethnicity
  Non-Hispanic White 8,126 24,141 73.5 72.3–74.7 1,161 2,985 72.4 69.2–75.3 6,613 20,084 73.9 72.6–75.2
  Non-Hispanic Black 1,700 4,298 13.1 12.3–14.0 244 568 13.8 11.6–16.3 1,355 3,485 12.8 11.9–13.8
  Hispanic 1,112 3,128 9.5 8.6–10.5 182 427 10.4 8.5–12.5 864 2,525 9.3 8.4–10.3
  Non-Hispanic other 442 1,272 3.9 3.4–4.4 58 143 3.5 2.4–5.0 359 1,070 3.9 3.4–4.5
 Education
  Less than high school 1,494 3,925 12.0 11.2–12.8 349 791 19.2 17.0–21.7 1,060 2,963 10.9 10.1–11.8
  High school or equivalent 3,049 8,937 27.3 26.2–28.4 449 1,206 29.3 26.3–32.6 2,440 7,263 26.8 25.6–28.1
  Associate degree/some college 3,947 11,038 33.7 32.5–34.9 582 1,396 33.9 30.9–37.1 3,178 9,088 33.5 32.2–34.9
  College graduate or above 2,864 8,850 27.0 25.8–28.3 263 720 17.5 15.2–20.1 2,491 7,779 28.7 27.4–30.1
 Employment status
  Employed 6,535 19,949 60.8 59.5–62.0 508 1,255 30.4 27.8–33.3 5,765 17,855 65.7 64.4–67.1
  Unemployed 472 1,352 4.1 3.7–4.6 116 303 7.4 5.7–9.4 329 982 3.6 3.1–4.2
  Unable to work/disabled 2,814 6,875 20.9 19.9–22.0 863 2,064 50.1 46.7–53.4 1,761 4,359 16.1 15.1–17.1
  Other 1,556 4,658 14.2 13.3–15.1 158 501 12.1 10.0–14.6 1,333 3,963 14.6 13.6–15.6
 Income-to-poverty ratio
  Poor (<125%) 2,935 6,571 20.0 19.0–21.1 796 1,690 41.0 37.6–44.4 1,937 4,451 16.4 15.3–17.5
  Low income (125–199%) 1,563 4,230 12.9 12.1–13.7 251 708 17.2 14.6–20.1 1,231 3,275 12.1 11.2–12.9
  Middle income (200–400%) 2,950 8,927 27.2 26.1–28.3 367 1,110 26.9 24.1–29.9 2,471 7,465 27.5 26.3–28.7
  High income (>400%) 3,933 13,110 39.9 38.6–41.3 231 615 14.9 12.8–17.4 3,552 11,974 44.1 42.6–45.6
 Social participation restriction
  Yes 1,150 2,851 8.7 8.0–9.4 455 1,051 25.5 22.7–28.5 615 1,550 5.7 5.1–6.3
  No 10,218 29,954 91.3 90.6–92.0 1,189 3,070 74.5 71.5–77.3 8,574 25,610 94.3 93.7–94.9

Health factors
 Self-rated health
  Excellent/very good 4,161 12,836 39.1 37.8–40.4 208 607 14.7 12.3–7.5 3,800 11,740 43.2 41.8–44.7
  Good 3,620 10,585 32.2 31.0–33.5 414 1,029 25.0 22.4–27.7 3,057 9,131 33.6 32.2–35.0
  Fair/poor 3,595 9,409 28.7 27.5–29.9 1,022 2,482 60.3 57.2–63.3 2,333 6,291 23.2 22.0–24.3
 Self-reported anxiety symptoms
  Yes 2,572 6,834 21.8 20.8–22.8 1,311 3,268 79.3 76.6–81.8 1,242 3,530 13.0 12.1–13.9
  No 8,284 24,504 78.2 77.2–79.2 332 852 20.7 18.2–23.4 7,933 23,600 87.0 86.1–87.9
 Body mass index, kg/m2
  Under/healthy weight (<25.0) 2,581 7,390 23.4 22.4–24.5 361 864 21.6 18.9–24.5 2,095 6,154 23.4 22.3–24.6
  Overweight (25.0–29.9) 3,377 9,902 31.4 30.3–32.5 428 1,096 27.4 24.4–30.6 2,814 8,443 32.1 30.9–33.4
  Obese (≥30.0) 4,965 14,256 45.2 43.9–46.5 811 2,043 51.0 47.5–54.6 3,982 11,700 44.5 43.1–45.9
 Number of comorbid conditions§
  0 4,003 12,260 37.3 36.1–38.6 347 984 23.9 21.0–27.0 3,472 10,728 39.5 38.1–40.9
  1–2 5,580 15,894 48.4 47.1–49.7 791 1,970 47.8 44.5–51.0 4,530 13,188 48.5 47.1–50.0
  ≥3 1,797 4,684 14.3 13.4–15.1 507 1,169 28.4 25.7–31.1 1,189 3,248 12.0 11.1–12.9
 Arthritis-attributable activity limitations
  Yes 5,199 14,288 43.5 42.2–44.9 1,185 2,883 70.0 66.8–73.0 3,707 10,545 38.9 37.5–40.2
  No 6,174 18,520 56.5 55.1–57.8 459 1,235 30.0 27.0–33.2 5,478 16,594 61.1 59.8–62.5
 Aerobic physical activity level
  Inactive 3,876 10,740 33.3 32.0–34.6 795 1,969 48.4 45.0–51.9 2,875 8,191 30.5 29.2–31.9
  Insufficiently active 2,519 7,423 23.0 21.9–24.1 366 944 23.2 20.4–26.3 2,066 6,257 23.3 22.1–24.5
  Active 4,773 14,107 43.7 42.4–45.0 456 1,154 28.4 5.4–31.6 4,129 12,403 46.2 44.8–47.6
 Functional limitations#
  0 6,851 20,729 63.2 61.9–64.4 491 1,332 32.3 29.2–35.6 6,086 18,569 68.4 67.1–69.6
  1–3 2,545 7,092 21.6 20.6–22.6 504 1,282 31.1 28.2–34.2 1,917 5,483 20.2 19.1–21.3
  ≥4 1,975 4,989 15.2 14.3–16.1 650 1,509 36.6 33.5–39.8 1,187 3,110 11.4 10.6–12.3

Health service use
 Ambulatory care visits in past year
  0–3 4,607 13,724 42.4 41.1–43.8 380 995 24.2 21.4–27.3 4,084 12,311 45.4 43.9–46.9
  4–9 3,457 9,947 30.7 29.6–32.0 484 1,224 29.8 26.9–32.9 2,852 8,349 30.8 29.5–32.1
  10–15 1,658 4,586 14.2 13.3–15.1 357 821 20.0 17.5–22.7 1,232 3,555 13.1 12.2–14.1
  ≥16 1,478 4,102 12.7 11.8–13.6 415 1,065 25.9 23.1–9.1 1,004 2,903 10.7 9.8–11.6
 Usual place for care
  Yes 10,486 30,203 92.6 91.8–93.4 1,530 3,812 92.5 90.5–94.1 8,517 25,150 92.6 91.6–93.4
  No 813 2,407 7.4 6.6–8.2 115 311 7.5 5.9–9.5 673 2,012 7.4 6.6–8.4
 Health insurance
  Not covered 1,136 3,108 9.5 8.8–10.3 189 584 14.2 12.0–16.8 904 2,413 8.9 8.1–9.8
  Covered 10,214 29,624 90.5 89.7–91.2 1,451 3,527 85.8 83.2–88.0 8,266 24,673 91.1 90.2–91.9
*

Doctor-diagnosed arthritis was identified by “yes” to the question “Have you ever been told by a doctor or other health professional that you have some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia?” For depressive symptoms, participants were asked about the frequency (“How often do you feel depressed?” [daily, weekly, monthly, a few times a year, never, or refused/don’t know]) and intensity (“Thinking about the last time you felt depressed, how depressed did you feel?” [a lot, in between a little and a lot, a little, or refused/don’t know]) of depressive symptoms. Participants were categorized as reporting depressive symptoms by reporting “daily” or “weekly” for symptom frequency and “a lot” or “in between a little and a lot” for depressive symptom intensity. 95% CI = 95% confidence interval.

Other refers to participants who are retired, homemakers, or students, but not otherwise working.

Calculated using imputed income files from the NHIS and based on total family income and family size.

§

Nine possible comorbid conditions examined were hypertension, heart diseases, stroke, diabetes mellitus, asthma, cancer, weak or failing kidneys, hepatitis, and chronic obstructive pulmonary disease.

Physically active (≥150 minutes moderate-intensity, leisure time, aerobic physical activity/week), insufficiently active (1–149 minutes moderate-intensity, leisure time, aerobic physical activity/week), inactive (0 minutes moderate-intensity, leisure time, aerobic physical activity/week).

#

Number of functional limitations was measured for 9 tasks (e.g., push/pull large objects, walk one-fourth mile, stand for 2 hours, sit for 2 hours, stoop/bend/kneel, reach over one’s head, grasp small objects, climb stairs, lift or carry 10 pounds); limitation was identified for responses of “very difficult” or “can’t do.”

The majority of the study population indicated no social participation restrictions (91%) or self-reported anxiety symptoms (78%). More than one-half of the population had no arthritis-attributable activity limitation (56%) or functional limitations (63%). Close to one-third indicated excellent/very good self-rated health (39%). Approximately one-half of participants reported obesity (45%) and 1–2 comorbid conditions (48%). An examination of health service use variables indicated that 42% of participants reported 0–3 ambulatory visits in the past year, and most reported having health insurance coverage (91%) and a usual place for care (93%) (Table 1).

The prevalence of depressive symptoms was 13% overall among working-age adults living with arthritis (Table 1). When compared with those not living with depressive symptoms, participants with depressive symptoms were more frequently women (57% versus 66%), were middle-age adults (45% versus 51%), reported less than a high school education (11% versus 19%), had an IPR <125% (16% versus 41%), and indicated a greater prevalence of social participation restrictions (6% versus 26%). No differences existed when comparing participants with and without depressive symptoms according to race/ethnicity. Of note, participants with depressive symptoms indicated a lower prevalence of employment (30%) in comparison with those not reporting depressive symptoms (66%). In addition, those with depressive symptoms indicated a greater prevalence of being unable to work/disabled (50%) when compared with those without depressive symptoms (16%) (Table 1 and Figure 1).

Figure 1.

Figure 1.

Prevalence of employment among working-age adults (ages 18–64 years) in the US with doctor-diagnosed arthritis, National Health Interview Survey, 2013–2017. Employment was compared between those with and without self-reported depressive symptoms and across age groups among adults with arthritis. See Materials and Methods for participant questions and categorizations.

When compared with those without depressive symptoms, participants reporting depressive symptoms more often had a higher prevalence of fair/poor health (23% versus 60%), anxiety symptoms (13% versus 79%), obesity (45% versus 51%), arthritis-attributable activity limitation (39% versus 70%), ≥4 functional limitations (11% versus 37%), and physical inactivity (31% versus 48%). When compared with those without depressive symptoms, those reporting depressive symptoms more frequently indicated a higher number of ambulatory visits (≥16) (11% versus 26%) and having no health insurance coverage (9% versus 14%). A similar frequency of participants with and without depressive symptoms indicated a usual place for care (Table 1).

Across all study variables, working-age adults with arthritis who reported depressive symptoms had a lower prevalence of employment when compared with those not reporting depressive symptoms (Table 2). For participants with depressive symptoms, younger adults (40%) more frequently reported employment when compared with older adults (26%) and middle-age adults (32%) (Table 2 and Figure 1). When compared with those not reporting depressive symptoms, employment prevalence among those with depressive symptoms was less frequent for men (71% versus 27%) and for those with an IPR <125% (36% versus 15%) and who indicated a social participation restriction (17% versus 10%). When compared with those not reporting depressive symptoms, employment prevalence among those reporting depressive symptoms was lowest for participants with fair/poor self-rated health (36% versus 16%), obesity (63% versus 29%), ≥3 comorbid conditions (40% versus 16%), arthritis-attributable activity limitation (46% versus 19%), and ≥4 functional limitations (19% versus 11%).

Table 2.

Weighted prevalence of employment participation among working-age US adults (ages 18–64 years) with doctor-diagnosed arthritis using 2013–2017 National Health Interview Survey (NHIS) data, comparing those with and without self-reported depressive symptoms*

Arthritis and depressive symptoms
Arthritis and no depressive symptoms
Sample size No. weighted, 1,000s % 95% CI Sample size No. weighted, 1,000s % 95% CI Absolute % difference
Total 508 1,255 30.4 27.8–33.3 5,765 17,855 65.7 64.4–67.1 35.3

Sociodemographic factors
 Sex
  Men 153 381 27.2 22.6–32.3 2,490 8,306 71.7 69.7–73.5 44.5
  Women 355 874 32.1 28.7–35.7 3,275 9,549 61.3 59.5–63.1 29.2
 Age, years
  Young adult (18–34) 63 176 39.7 29.3–51.2 600 1,950 72.1 68.0–75.8 32.3
  Middle-age adult (35–54) 254 673 32.2 28.0–36.7 2,732 8,940 73.1 71.2–74.9 40.8
  Older adult (55–64) 191 406 25.5 21.6–29.9 2,433 6,965 57.0 55.1–58.9 31.5
 Race/ethnicity
  Non-Hispanic White 383 947 31.7 28.6–35.1 4,298 13,586 67.7 66.1–69.2 35.9
  Non-Hispanic Black 51 126 22.1 15.9–29.9 723 2,043 58.7 55.0–62.2 36.5
  Hispanic 53 128 30.0 22.0–39.4 523 1,564 61.9 57.3–66.3 31.9
  Non-Hispanic other 54 37.6 22.5–55.6 221 663 61.9 54.8–68.5 24.3
 Education
  Less than high school 48 119 15.0 10.3–21.3 446 1,338 45.1 40.9–49.4 30.1
  High school or equivalent 118 302 25.0 20.3–30.3 1,348 4,266 58.8 56.1–61.3 33.8
  Associate degree/some college 201 458 32.8 28.2–37.8 2,006 5,957 65.6 63.3–67.7 32.7
  College graduate or above 140 371 51.5 44.2–58.8 1,956 6,266 80.6 78.4–82.6 29.1
 Income-to-poverty ratio§
  Poor (<125%) 124 253 14.9 12.0–18.5 597 1,602 36.0 32.9–39.2 21.0
  Low income (125–199%) 76 198 28.0 21.4–35.8 632 1,634 49.9 45.9–53.9 21.9
  Middle income (200–400%) 167 462 41.6 35.3–48.3 1,667 4,968 66.6 63.9–69.1 24.9
  High income (>400%) 140 342 55.6 47.8–63.2 2,869 9,651 80.6 78.8–82.3 25.0
 Social participation
  Yes 50 100 9.5 6.8–13.1 92 255 16.5 12.9–20.7 6.9
  No 458 1,155 37.6 34.3–41.1 5,671 17,596 68.7 67.3–70.1 31.1

Health factors
 Self-rated health
  Excellent/very good 136 355 58.5 48.6–67.8 3,000 9,338 79.5 77.8–81.1 21.0
  Good 199 516 50.1 44.3–56.0 2,040 6,271 68.7 66.3–71.0 18.6
  Fair/poor 173 384 15.5 12.9–18.5 725 2,246 35.7 33.0–38.5 20.2
 Self-reported anxiety symptoms
  Yes 390 951 29.1 26.0–32.4 633 1,944 55.1 51.2–58.9 26.0
  No 118 304 35.7 29.3–42.7 5,125 15,895 67.4 65.9–68.8 31.6
*

Doctor-diagnosed arthritis was identified by “yes” to the question “Have you ever been told by a doctor or other health professional that you have some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia?” For depressive symptoms, participants were asked about the frequency (“How often do you feel depressed?” [daily, weekly, monthly, a few times a year, never, or refused/don’t know]) and intensity (“Thinking about the last time you felt depressed, how depressed did you feel?” [a lot, in between a little and a lot, a little, or refused/don’t know]) of depressive symptoms. Participants were categorized as reporting depressive symptoms by reporting “daily” or “weekly” for symptom frequency and “a lot” or “in between a little and a lot” for depressive symptom intensity. 95% CI = 95% confidence interval.

Significance of all absolute differences was based on a t-test, with P < 0.0001.

Estimates with a relative SE 20.0–29.9% were considered unstable and should be interpreted with caution; estimates based on <30 unweighted cases are not reported.

§

Calculated using imputed income files from the NHIS and based on total family income and family size.

The unadjusted and multivariable-adjusted relationship between employment and each study variable is shown in Table 3. The unadjusted model indicated that having depressive symptoms was significantly associated with a lower likelihood of employment (prevalence ratio 0.46 [95% CI 0.42–0.51]). Findings from the multivariable-adjusted model indicated that, when controlling for all other variables in the model, depressive symptoms among working-age adults with arthritis were significantly associated with not participating in employment (prevalence ratio 0.88 [95% CI 0.83–0.93]). Middle-age adults reporting depressive symptoms were significantly less likely to be employed (prevalence ratio 0.83 [95% CI 0.77–0.90]) when compared with middle-age counterparts not reporting depression; we found borderline statistically significant associations between depression and employment for both younger (prevalence ratio 0.86 [95% CI 0.74–0.99]) and older adults (prevalence ratio 0.94 [95% CI 0.86–1.03]).

Table 3.

Univariable and multivariable prevalence ratios (PRs) for the relationship between study variables (sociodemographic characteristics, health factors, and health service use) and employment among adults (ages 18–64 years) in the US with doctor-diagnosed arthritis, National Health Interview Survey (NHIS), 2013–2017*

Univariable
Multivariable
PR 95% CI PR 95% CI
Depressive symptoms
 Yes 0.46 0.42–0.51 0.88 0.83–0.93
 No 1.00 1.00

Sociodemographic factors
 Sex
  Men 1.00 1.00
  Women 0.85 0.82–0.88 0.92 0.89–0.95
 Age, years
  Young adult (18–34) 1.0 1.00
  Middle-age adult (35–54) 0.98 0.92–1.05 1.04 0.99–1.09
  Older adult (55–64) 0.79 0.74–0.84 0.84 0.77–0.89
 Race/ethnicity
  Non-Hispanic White 1.00
  Non-Hispanic Black 0.84 0.79–0.90
  Hispanic 0.91 0.85–0.99
  Non-Hispanic other 0.93 0.84–1.04
 Education
  Less than high school 0.71 0.65–0.79
  High school or equivalent 1.00
  Some college/associate degree 1.14 1.08–1.21
  College graduate or above 1.46 1.39–1.53
 Income-to-poverty ratio§ 1.00
  Poor (<125%) 1.50 1.33–1.70 1.21 1.10–1.32
  Low income (125–199%) 2.10 1.92–2.30 1.44 1.34–1.55
  Middle income (200–400%) 2.63 2.42–2.87 1.65 1.53–1.77
  High income (>400%) 1.00
 Social participation
  Yes 0.22 0.18–0.26 0.78 0.70–0.88
  No 1.00 1.00

Health factors
 Self-rated health
  Excellent/very good 1.00 1.00
  Good 0.85 0.81–0.88 1.00 0.96–1.05
  Fair/poor 0.38 0.36–0.41 0.83 0.78–0.88
 Self-reported anxiety symptoms
  Yes 0.64 0.60–0.69
  No 1.00
 Body mass index, kg/m2
  Under/healthy weight (<25.0) 1.00
  Overweight (25.0–29.9) 1.06 1.01–1.12
  Obese (≥30.0) 0.94 0.89–1.00
 Number of comorbid conditions
  0 1.00 1.00
  1–2 0.80 0.77–0.83 0.95 0.91–0.99
  ≥3 0.44 0.40–0.49 0.90 0.85–0.96
 Arthritis-attributable activity limitations
  Yes 0.53 0.51–0.56 0.84 0.81–0.88
  No 1.00 1.00
 Aerobic physical activity level#
  Inactive 1.00
  Insufficiently active 1.37 1.29 –1.46
  Active 1.56 1.48 –1.64
 Functional limitations**
  0 1.00 1.00
  1–3 0.59 0.55–0.62 0.85 0.81–0.90
  ≥4 0.22 0.19–0.26 0.70 0.61–0.78

Health service use
 Ambulatory care visits in past year
  0–3 1.00 1.00
  4–9 0.82 0.79–0.86 0.94 0.90–0.98
  10–15 0.66 0.62–0.71 0.91 0.87–0.96
  ≥16 0.58 0.54–0.64 0.93 0.93–0.99
 Usual place for care
  Yes 0.98 0.91 - 1.06
  No 1.00
 Health insurance
  Not covered 1.00
  Covered 1.17 1.09–1.26

Interaction effects of depressive symptoms (age, years)††
 Young adult (18–34) 0.86 0.74–0.99
 Middle-age adult (35–54) 0.83 0.77–0.90
 Older adults (55–64) 0.94 0.86–1.03
*

Doctor-diagnosed arthritis was identified by“yes” to the question “Have you ever been told by a doctor or other health professional that you have some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia?” 95% CI = 95% confidence interval.

For depressive symptoms, participants were asked about the frequency (“How often do you feel depressed?” [daily, weekly, monthly, a few times a year, never, or refused/don’t know]) and intensity (“Thinking about the last time you felt depressed, how depressed did you feel?” [a lot, in between a little and a lot, a little, or refused/don’t know]) of depressive symptoms. Participants were categorized as reporting depressive symptoms by reporting “daily” or “weekly” for symptom frequency and “a lot” or “in between a little and a lot” for depressive symptom intensity.

Variable not included in the multivariable model as a result of our backwards elimination strategy.

§

Calculated using imputed income files from the NHIS and based on total family income and family size.

Nine possible comorbid conditions examined were hypertension, heart diseases, stroke, diabetes mellitus, asthma, cancer, weak or failing kidneys, hepatitis, and chronic obstructive pulmonary disease.

#

Physically active (≥150 minutes moderate-intensity, leisure time, aerobic physical activity/week), insufficiently active (1–149 minutes moderate-intensity, leisure time, aerobic physical activity/week) or inactive (0 minutes moderate-intensity, leisure time, aerobic physical activity/week).

**

Number of functional limitations was measured for 9 tasks (e.g., push/pull large objects, walk one-fourth mile, stand for 2 hours, sit for 2 hours, stoop/bend/kneel, reach over one’s head, grasp small objects, climb stairs, lift or carry 10 pounds); limitation was identified for responses of “very difficult” or “can’t do.”

††

Reference is no depressive symptoms.

DISCUSSION

Employment is a critical social determinant of health that provides access to income and other resources that support health and quality of life (39). Individuals living with different forms of arthritis are more likely to live with depressive symptoms when compared with those not living with arthritis. The co-occurrence of arthritis and depression can play a significant role in shaping labor market experiences. Using a nationally representative US population health survey, we examined the association between self-reported depressive symptoms and employment among a large sample of working-age adults with arthritis. Findings indicated that depression was significantly associated with not participating in employment. The relationship between depression and not participating in employment was most significant for young and middle-age adults with arthritis. Our findings underscore the substantial negative impact of depression in the workforce engagement of individuals living with arthritis and highlights the need for additional research to unpack the relationship between mental health, employment participation, and arthritis conditions among working-age people. Results also provide additional support for the consideration of mental health in designing and tailoring of workplace policies and programs for individuals with arthritis.

Our study is one of the first to examine the interrelationship between self-reported depression, arthritis, and employment in a nationally representative population-level survey of US adults. Supporting our first hypothesis, we found that working-age adults with doctor-diagnosed arthritis who also reported depression were less likely to participate in employment when compared to their counterparts without depression. Aligning with previous research, participants in our study who reported both arthritis and depressive symptoms were more likely to indicate fair/poor self-rated health, arthritis-attributable activity limitation, and a social participation restriction (19,20,22). Acknowledging that the study findings are cross-sectional is important, and we cannot establish causality. At the same time, several potential mechanisms could explain the results. Perhaps depressive symptoms can exacerbate the employment participation restrictions faced by individuals with arthritis (19). Alternatively, arthritis-related work disability could be a stressor that contributes to depressive symptoms. More likely, arthritis, depression, and employment are reciprocally related to one another. Longitudinal research is required to examine the interconnection between arthritis, depression, and employment participation. In addition, we acknowledge that different forms of arthritis have distinct pathophysiology results and concomitant symptoms and require different pharmacologic and nonpharmacologic treatment. Research examining the impact of depression on employment should be conducted in participants with different arthritis diagnoses to develop tailored work disability prevention recommendations.

Nonetheless, our study adds preliminary support for the health and economic benefits of treating depressive symptoms among people living with arthritis. Studies of individuals with and without arthritis highlight clinical and labor market benefits of certain mental health care treatments (e.g., cognitive behavioral therapy or mindfulness-based stress reduction) (4042). Attention has also been directed to workplace-based mental health treatment (e.g., work-focused cognitive behavioral therapy) and accommodations (e.g., workplace flexibility) to prevent work disability of people with depression (43,44). In light of our study findings, mental health care could be especially beneficial for those experiencing a co-occurrence of arthritis and depression who are not participating in employment, and such health care could complement existing evidence-based programs that address the physical arthritis symptoms to prevent work disability (45,46). Importantly, other research indicates that mental health care services are often underused in individuals with and without arthritis (21,47,48). Underuse of mental health care has been attributed to gaps in health insurance coverage, high costs of care, lack of recognition of depressive symptoms and referral from a treating physician, and challenges faced by people with depression in communicating symptoms (21,48). More research is required to examine ways in which different forms of mental health care can be integrated into clinical and workplace practices for people with arthritis and to identify strategies that encourage access to treatment. Additional research is also needed to examine the effectiveness of workplace- and nonworkplace-based mental health treatments in supporting the employment of individuals with arthritis.

Among working-age adults with arthritis, the prevalence of depression and its impact on labor market activity differs across the life course. Interestingly, our study indicated that middle-age adults with arthritis were more likely to report depression when compared with young and older working-age respondents with arthritis. In contrast to our second study hypothesis, findings from our multivariable model indicated that, although borderline, depression in middle-age adults with arthritis was related to not participating in employment. Previous research finds that middle-age adults report that arthritis can have a particular impact on involvement in a number of valued social roles, including employment and family life (32,49). The co-occurrence of arthritis and depression has the potential to exacerbate participation restrictions during this period. Study findings can be interpreted within the context of a decreasing life expectancy in the US population. Recent population-level data indicate that middle-age adults are experiencing the most significant retrogression of all-cause mortality (50). Promoting the labor market participation of people with arthritis and depression, especially of middle-age adults, provides a pathway to improving health and quality of life and decreasing mortality (39,50). Although borderline significant, our study found that young adult participants reporting depression were less likely to be employed. For individuals with arthritis, depression at younger ages has the potential to impact entry into the labor market and employment across the life course. To advance our findings, more evidence is needed to understand how depression can impact employment participation at different ages and stages of working life. Indeed, additional research specifically on young adults with arthritis could reveal insights on the impact of mental health during the school-to-work transition. Research is required to examine the potential immediate and longer-term benefits of mental health treatment and interventions that are targeted to middle-age adults with arthritis.

There are several study strengths and limitations to acknowledge. Using the NHIS, we were able to capture a large, representative sample of young, middle-age, and older working-age adults with arthritis, including osteoarthritis, rheumatoid arthritis, gout, lupus, fibromyalgia, or other forms of rheumatic disease and to collect a range of sociodemographic, health, and health service use characteristics. While self-reported measures do not substitute for a clinical diagnosis, they are often considered valid case-finding questions for public health surveillance (5,31). It is also important to highlight that both arthritis and depression are considered episodic conditions, with symptoms that fluctuate in severity, and we are unable to highlight the unpredictable interruptions to employment that stem from both physical and mental health conditions. Last, our study focuses only on employment status as the main work outcome measures. Additional research is required to elaborate on the relationship between depressive symptoms and at-work experiences (e.g., absenteeism and presenteeism) of people with arthritis.

Among working-age adults living with arthritis, depression can significantly limit labor market participation. The association between depression and employment may be more salient for middle-age adults and potentially for young adults with arthritis. We provide an important foundation for future research to unpack the relationship between arthritis, depression, and workforce engagement. Of significance, our findings point to the importance of considering mental health in the design and delivery of policies and programs within workplace, community, and clinical settings that support the employment of individuals with arthritis.

SIGNIFICANCE & INNOVATIONS.

  • At the population-level, our study is one of the first to show the age-specific relationship between arthritis, depressive symptoms, and employment in the US using a nationally representative survey.

  • Among working-age adults with arthritis, we present evidence of the striking relationship between reporting depressive symptoms and not participating in employment.

  • Our study points to the importance of prioritizing mental health initiatives that address work disability for adults living with arthritis.

  • The relationship between depressive symptoms and not participating in employment was the most pronounced for middle-age adults, which suggests a need for the design of age-specific interventions.

Acknowledgments

The findings and conclusions herein are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Dr. Jetha’s work was supported by a Young Investigator Operating Grant from the Arthritis Society, Canada. Ms Guglielmo’s work was supported by an appointment to the Research Participation Program at the Division of Population Health, Arthritis Program, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the Centers for Disease Control and Prevention.

Footnotes

No potential conflicts of interest relevant to this article were reported.

REFERENCES

  • 1.Theis KA, Roblin DW, Helmick CG, Luo R. Prevalence and causes of work disability among working-age US adults, 2011–2013, NHIS. Disabil Health J 2018;11:108–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Jetha A, Badley E, Beaton D, Fortin PR, Shift NJ, Gignac MA. Unpacking early work experiences of young adults with rheumatic disease: an examination of absenteeism, job disruptions, and productivity loss. Arthritis Care Res (Hoboken) 2015;67:1246–54. [DOI] [PubMed] [Google Scholar]
  • 3.Burton W, Morrison A, Maclean R, Ruderman E. Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond) 2005;56:18–27. [DOI] [PubMed] [Google Scholar]
  • 4.Martikainen JA, Kautiainen H, Rantalaiho V, Puolakka KT. Longterm work productivity costs due to absenteeism and permanent work disability in patients with early rheumatoid arthritis: a nationwide register study of 7,831 patients. J Rheumatol 2016;43:2101–5. [DOI] [PubMed] [Google Scholar]
  • 5.Guglielmo D, Hootman JM, Boring MA, Murphy LB, Theis KA, Croft JB, et al. Symptoms of anxiety and depression among adults with arthritis: United States, 2015–2017. MMWR Morb Mortal Wkly Rep 2018;67:1081–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Dickens C, McGowan L, Clark-Carter D, Creed F. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002;64:52–60. [DOI] [PubMed] [Google Scholar]
  • 7.Barbour KE, Helmick CG, Boring M, Brady TJ. Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation. United States, 2013–2015. MMWR Morb Mortal Wkly Rep 2017;66:246–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Li X, Gignac MA, Anis AH. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work. Med Care 2006;44:304–10. [DOI] [PubMed] [Google Scholar]
  • 9.Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol 2002;29:1989–99. [PubMed] [Google Scholar]
  • 10.Gignac MA, Cao X, Tang K, Beaton DE. Examination of arthritis-related work place activity limitations and intermittent disability over four-and-a-half years and its relationship to job modifications and outcomes. Arthritis Care Res (Hoboken) 2011;63:953–62. [DOI] [PubMed] [Google Scholar]
  • 11.Gignac MA, Cao X, McAlpine J. Availability, need for, and use of work accommodations and benefits: are they related to employment outcomes in people with arthritis? Arthritis Care Res (Hoboken) 2015;67:855–64. [DOI] [PubMed] [Google Scholar]
  • 12.Lacaille D, Sheps S, Spinelli JJ, Chalmers A, Esdaile JM. Identification of modifiable work-related factors that influence the risk of work disability in rheumatoid arthritis. Arthritis Rheum 2004;51:843–52. [DOI] [PubMed] [Google Scholar]
  • 13.De Croon E, Sluiter J, Nijssen T, Dijkmans B, Lankhorst G, Frings-Dresen M. Predictive factors of work disability in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2004;63:1362–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Jetha A, Bowring J, Tucker S, Connelly CE, Martin Ginis KA, Proulx L, et al. Transitions that matter: life course differences in the employment of adults with arthritis. Disabil Rehab 2018;40:3127–35. [DOI] [PubMed] [Google Scholar]
  • 15.Pincus T, Esther R, DeWalt DA, Callahan LF. Social conditions and self-management are more powerful determinants of health than access to care. Ann Intern Med 1998;129:406–11. [DOI] [PubMed] [Google Scholar]
  • 16.Margaretten M, Barton J, Julian L, Katz P, Trupin L, Tonner C, et al. Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2011;63:240–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Murphy LB, Cisternas MG, Pasta DJ, Helmick CG, Yelin EH. Medical expenditures and earnings losses among US adults with arthritis in 2013. Arthritis Care Res (Hoboken) 2018;70:869–76. [DOI] [PubMed] [Google Scholar]
  • 18.Rosemann T, Backenstrass M, Joest K, Rosemann A, Szecsenyi J, Laux G. Predictors of depression in a sample of 1,021 primary care patients with osteoarthritis. Arthritis Rheum 2007;57:415–22. [DOI] [PubMed] [Google Scholar]
  • 19.Katz P, Margaretten M, Trupin L, Schmajuk G, Yazdany J, Yelin E. Role of sleep disturbance, depression, obesity, and physical inactivity in fatigue in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2016;68:81–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hawker GA, Gignac MA, Badley E, Davis AM, French MR, Li Y, et al. A longitudinal study to explain the pain-depression link in older adults with osteoarthritis. Arthritis Care Res (Hoboken) 2011;63:1382–90. [DOI] [PubMed] [Google Scholar]
  • 21.Margaretten M, Julian L, Katz P, Yelin E. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumatol 2011;6:617–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Machado GP, Gignac MA, Badley EM. Participation restrictions among older adults with osteoarthritis: a mediated model of physical symptoms, activity limitations, and depression. Arthritis Care Res (Hoboken) 2008;59:129–35. [DOI] [PubMed] [Google Scholar]
  • 23.Jetha A, Besen E, Smith PM. Comparing the relationship between age and length of disability across common chronic conditions. J Occup Environ Med 2016;58:485–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Lerner D, Adler DA, Rogers WH, Lapitsky L, McLaughlin T, Reed J. Work performance of employees with depression: the impact of work stressors. Am J Health Promot 2010;24:205–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bielecky A, Chen C, Ibrahim S, Beaton DE, Mustard CA, Smith PM. The impact of co-morbid mental and physical disorders on presenteeism. Scand J Work Environ Health 2015:554–64. [DOI] [PubMed] [Google Scholar]
  • 26.Veldman K, Reijneveld SA, Verhulst FC, Ortiz JA, Bültmann U. A life course perspective on mental health problems, employment, and work outcomes. Scand J Work Environ Health 2017;43:316–25. [DOI] [PubMed] [Google Scholar]
  • 27.Dewa CS, Lin E, Kooehoorn M, Goldner E. Association of chronic work stress, psychiatric disorders, and chronic physical conditions with disability among workers. Psychiatr Serv 2007;58:652–8. [DOI] [PubMed] [Google Scholar]
  • 28.Kessler RC, Ormel J, Demler O, Stang PE. Comorbid mental disorders account for the role impairment of commonly occurring chronic physical disorders: results from the National Comorbidity Survey. J Occup Environ Med 2003;45:1257–66. [DOI] [PubMed] [Google Scholar]
  • 29.Brody DJ, Pratt LA, Hughes JP. Prevalence of depression among adults aged 20 and over: United States, 2013–2016. NCHS Data Brief. no. 303. Hyattsville (MD): National Center for Health Statistics; 2018. [PubMed] [Google Scholar]
  • 30.National Center for Health Statistics. National Health Interview Survey, 2017: public-use data file and documentation, 2018. URL: https://www.cdc.gov/nchs/nhis/data-questionnaires-documentation.htm.
  • 31.Sacks JJ, Harrold LR, Helmick CG, Gurwitz JH, Emani S, Yood RA. Validation of a surveillance case definition for arthritis. J Rheumatol 2005;32:340–7. [PubMed] [Google Scholar]
  • 32.Jetha A, Gignac MA, Bowring J, Tucker S, Connelly CE, Proulx L, et al. Supporting arthritis and employment across the life course: a qualitative study. Arthritis Care Res (Hoboken) 2018;70:1461–8. [DOI] [PubMed] [Google Scholar]
  • 33.National Center for Health Statistics. Multiple imputation of family income and personal earnings in the National Health Interview Survey: methods and examples, 2017. URL: https://www.cdc.gov/nchs/data/nhis/tecdoc17.pdf.
  • 34.Goodman RA, Posner SF, Huang ES, Parekh AK, Koh HK. Defining and measuring chronic conditions: imperatives for research, policy, program, and practice. Prev Chronic Dis 2013;10:120239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.US Department of Health and Human Services. Physical activity guidelines for Americans. 2nd ed. Washington (DC): Department of Health and Human Services; 2018. [Google Scholar]
  • 36.Knezevic A. Overlapping confidence intervals and statistical significance. Ithaca (NY): Cornell University; 2008. [Google Scholar]
  • 37.SAS Institute Inc. SAS/STAT 9.3 user’s guide. Version 9.3 ed. Cary (NC): SAS Institute; 2011. [Google Scholar]
  • 38.Research Triangle Institute. SUDAAN language manual, vols. 1 and 2, release 11. Research Triangle Park (NC): Research Triangle Institute; 2012. [Google Scholar]
  • 39.Marmot M. Social determinants of health inequalities. Lancet 2005;365:1099–104. [DOI] [PubMed] [Google Scholar]
  • 40.Layard R. The case for psychological treatment centres. BMJ 2006;332:1030–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Cuijpers P, van Straten A, Warmerdam L. Behavioral activation treatments of depression: a meta-analysis. Clin Psychol Rev 2007;27:318–26. [DOI] [PubMed] [Google Scholar]
  • 42.Pradhan EK, Baumgarten M, Langenberg P, Handwerger B, Gilpin AK, Magyari T, et al. Effect of mindfulness-based stress reduction in rheumatoid arthritis patients. Arthritis Rheum 2007;57:1134–42. [DOI] [PubMed] [Google Scholar]
  • 43.Joyce S, Modini M, Christensen H, Mykletun A, Bryant R, Mitchell PB, et al. Workplace interventions for common mental disorders: a systematic meta-review. Psychol Med 2016;46:683–97. [DOI] [PubMed] [Google Scholar]
  • 44.Irvin E, Cullen C, Van Eerd D, Saunders R, Johnson L, Bornstein S, et al. Managing depression in the workplace: a systematic review contextualized for Manitoba: Institute for Work & Health and SafetyNet Centre for Occupational Health and Safety Research, 2017. URL: https://www.iwh.on.ca/scientific-reports/managing-depression-in-workplace-systematic-review-contextualized-for-manitoba.
  • 45.Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain 2002;18:355–65. [DOI] [PubMed] [Google Scholar]
  • 46.Keysor JJ, LaValley MP, Brown C, Felson DT, AlHeresh RA, Vaughan MW, et al. Efficacy of a work disability prevention program for people with rheumatic and musculoskeletal conditions: a single-blind parallel-arm randomized controlled trial. Arthritis Care Res (Hoboken) 2018;70:1022–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Machin A, Hider S, Dale N, Chew-Graham C. Improving recognition of anxiety and depression in rheumatoid arthritis: a qualitative study in a community clinic. Br J Gen Pract 2017;67:e531–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Hagglund KJ, Clark MJ, Hilton SA, Hewett JE. Access to healthcare services among persons with osteoarthritis and rheumatoid arthritis. Am J Phys Med Rehabil 2005;84:702–11. [DOI] [PubMed] [Google Scholar]
  • 49.Gignac MA, Backman CL, Kaptein S, Lacaille D, Beaton DE, Hofstetter C, et al. Tension at the borders: perceptions of role overload, conflict, strain and facilitation in work, family and health roles among employed individuals with arthritis. Rheumatology (Oxford) 2011;51:324–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Woolf SH, Schoomaker H. Life expectancy and mortality rates in the United States, 1959–2017. JAMA 2019;322:1996–2016. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES